Search Orphan Drug Designations and Approvals
-
Generic Name: | Angiotensin (1-7) |
---|---|
Date Designated: | 09/01/2016 |
Orphan Designation: | Treatment of recessive dystrophic epidermolysis bullosa (RDEB). |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Constant Therapeutics LLC 303 Congress St, c/o Casner & Edwards Boston, Massachusetts 02210 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-